Thrombopoietic growth factors
| First-generation thrombopoietic growth factors |
| Recombinant human thrombopoietins |
| rhTPO |
| PEG-rHuMGDF |
| Recombinant TPO fusion proteins |
| Promegapoietin (TPO/IL3 fusion protein) |
| Second-generation thrombopoietic growth factors |
| TPO peptide mimetics |
| Fab 59 |
| AMG 531 |
| Peg-TPOmp |
| TPO nonpeptide mimetics |
| Eltrombopag (SB497115, Promacta) |
| AKR-501 |
| TPO agonist antibodies |
| Minibodies [VB22B sc(Fv)2] |
| Domain subclass-converted TPO agonist antibodies (MA01G4G344) |
| First-generation thrombopoietic growth factors |
| Recombinant human thrombopoietins |
| rhTPO |
| PEG-rHuMGDF |
| Recombinant TPO fusion proteins |
| Promegapoietin (TPO/IL3 fusion protein) |
| Second-generation thrombopoietic growth factors |
| TPO peptide mimetics |
| Fab 59 |
| AMG 531 |
| Peg-TPOmp |
| TPO nonpeptide mimetics |
| Eltrombopag (SB497115, Promacta) |
| AKR-501 |
| TPO agonist antibodies |
| Minibodies [VB22B sc(Fv)2] |
| Domain subclass-converted TPO agonist antibodies (MA01G4G344) |